Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Schedule of Company's Condensed Consolidated Statement of Comprehensive Income and Cash Flows

The cumulative effect of the changes made to the Company's Condensed Consolidated Balance Sheets was as follows:

June 30, 2023	As Reported		As computed excluding anticipated net  investment income		Effect of Change
	(in thousands)
Premium deficiency reserve	$	291	$	2,681	$	(2,390)
Total current liabilities	907,758		910,148		(2,390)
Total liabilities	927,427		929,817		(2,390)
Accumulated deficit	(2,047,853)		(2,050,243)		2,390
Total stockholders' equity	330,570		328,180		2,390
Total liabilities and stockholders' equity	$	1,257,997	$	1,257,997	$	—

December 31, 2022	As Reported		Effect of Change		As Adjusted
	(in thousands)
Premium deficiency reserve	$	16,388	$	(9,149)	$	7,239
Total current liabilities	440,656		(9,149)		431,507
Total liabilities	460,882		(9,149)		451,733
Accumulated deficit	(1,955,582)		9,149		(1,946,433)
Total stockholders' equity	347,738		9,149		356,887
Total liabilities and stockholders' equity	$	808,620	$	—	$	808,620

December 31, 2021	As Reported		Effect of Change		As Adjusted
	(in thousands)
Premium deficiency reserve	$	110,628	$	(723)	$	109,905
Total current liabilities	372,624		(723)		371,901
Total liabilities	411,487		(723)		410,764
Accumulated deficit	(1,616,738)		723		(1,616,015)
Total stockholders' equity	539,317		723		540,040
Total liabilities and stockholders' equity	$	950,804	$	—	$	950,804

The effect of the changes made to the Company's Condensed Consolidated Statements of Comprehensive Loss was as follows:

Three Months Ended June 30, 2023	As Reported		As computed excluding anticipated net investment income		Effect of Change
	(in thousands)
Premium deficiency reserve benefit	$	(5,138)	$	(9,610)	$	4,472
Total operating expenses	542,435		537,963		4,472
Loss from operations	(28,807)		(24,335)		(4,472)
Net loss	$	(28,814)	$	(24,342)	$	(4,472)
Per share data:
Net loss per share attributable to Class A and B common stockholders - basic and diluted	$	(0.06)	$	(0.05)	$	(0.01)

Three Months Ended June 30, 2022	As Reported		Effect of Change		As Adjusted
	(in thousands)
Premium deficiency reserve benefit	$	(27,657)	$	181	$	(27,476)
Total operating expenses	949,246		181		949,427
Loss from operations	(102,546)		(181)		(102,727)
Net loss	$	(104,181)	$	(181)	$	(104,362)
Per share data:
Weighted shares outstanding	476,061,809		476,061,809		476,061,809
Net loss per share attributable to Class A and B common stockholders - basic and diluted	$	(0.22)	$	—	$	(0.22)

Six Months Ended June 30, 2023	As Reported		As computed excluding anticipated net investment income		Effect of Change
	(in thousands)
Premium deficiency reserve benefit	$	(6,948)	$	(13,707)	$	6,759
Total operating expenses	1,142,816		1,149,575		6,759
Loss from operations	(101,413)		(108,172)		(6,759)
Net loss	$	(101,420)	$	(108,179)	$	(6,759)
Per share data:
Net loss per share attributable to Class A and B common stockholders - basic and diluted	$	(0.21)	$	(0.23)	$	(0.02)

Six Months Ended June 30, 2022	As Reported		Effect of Change		As Adjusted
	(in thousands)
Premium deficiency reserve benefit	$	(55,314)	$	362	$	(54,952)
Total operating expenses	1,910,925		362		1,911,287
Loss from operations	(189,846)		(362)		(190,208)
Net loss	$	(179,490)	$	(362)	$	(179,852)
Per share data:
Net loss per share attributable to Class A and B common stockholders - basic and diluted	$	(0.38)	$	—	$	(0.38)

There was no impact on the Condensed Consolidated Statements of Cash Flows.